Objective: Retinopathy impacts over one-third of those with diabetes mellitus and is associated with impaired cognitive performance and cerebrovascular lesions in middle-aged adults with type 1 diabetes. However, the association between diabetic retinopathy (DR) and risk of dementia in type 1 diabetes is unknown. We investigated the association between DR and incident dementia in a large, elderly population with type 1 diabetes.
A dvances in medical care have allowed patients with T1D to reach higher ages than ever before by preventing or delaying severe complications. 1 Unfortunately, the increase in longevity provides new challenges. Recent studies have indicated that patients with T1D may be at increased risk for dementia. [2] [3] [4] This is concerning, as T1D treatment relies heavily on the patients' cognitive abilities, and treatment mistakes could potentially be fatal. As there is currently no curative treatment for dementia, exploration of potentially modifiable risk factors is imperative towards better clinical care and preventative measures.
Diabetic retinopathy (DR) impacts > 33% of adult individuals with type 1 diabetes. 5 In DR, the retinal microvascular circulation is damaged by the effects of diabetes. Recently, the retinal microvasculature has been gaining interest as a possible in vivo marker of brain integrity because of the high correlation with the state of the cerebral microvasculature. Indeed, retinal and cerebral microvasculature have similar embryological origin, similar anatomic features and physiological properties. Furthermore, several studies have found a associations between retinal microvascular changes and dementia risk in the general population, and with poorer cognitive performance and cerebrovascular lesions in younger populations of type 1 diabetes. 6 The hypothesis of DR being associated with increased dementia risk is supported by previous work in older patients with type 2 diabetes. 7 However, data on type 2 diabetes cannot be extrapolated to type 1 diabetes, as there are marked differences in disease origin, onset and treatment between types 1 and 2 diabetes. To the best of our knowledge, determinants of a relationship between type 1 diabetes and clinically diagnosed dementia have not been studied before, thus it is currently completely unknown whether, and how, DR affects dementia risk in type 1 diabetes.
Exploring processes linking type 1 diabetes and dementia can aid in unraveling the pathogenesis of dementia and its relationship to diabetes. If microvascular changes or other pathophysiological processes involved in the development of DR significantly contribute to development of dementia in older patients with type 1 diabetes, the presence of DR is expected to be associated with dementia in this cohort. Furthermore, if associated with dementia, DR could serve as an easily measurable and serially evaluable marker to aid clinicians in targeted dementia prevention and screening. In the current study, we aim to investigate whether DR is associated with an increased risk of dementia during follow-up in a large, well-defined cohort of older patients with type 1 diabetes.
METHODS

Study Population
For this study, we evaluated all members of Kaiser Permanente Northern California (KPNC) database for eligibility during the study period. KPNC is a large, integrated healthcare delivery system that provides comprehensive medical care to over 30% of the geographical region (3 million members). The population of KPNC generally provide a good representation of the overall regional population, with the exception of extreme tails of the income distribution. 8, 9 Senior (65 y and above) members of KPNC are similar to seniors residing in the region with respect to history of chronic conditions, including diabetes, hypertension, heart disease and lifestyle factors (eg, smoking, a sedentary lifestyle and obesity).
Analytic Cohort
Members of KPNC with type 1 diabetes, with no prevalent dementia diagnoses, and at least 50 years old at any time within the study period (January 1, 1996 until September 30, 2015) were eligible for our dynamic cohort. Patients were considered to have type 1 diabetes if they fit all 3 of the following criteria: 10 (a) had either 2 International Statistical Classification of Diseases, ninth edition (ICD-9) codes for type 1 diabetes without any type 2 diabetes codes, or a ratio of type 1: type 2 diabetes ICD-9 codes ≥ 0.75 in the Kaiser Permanente electronic database since start of membership, (b) filled insulin prescriptions during the study period, and (c) did not have filled prescriptions of any hypoglycemic agent other than insulin or metformin. Both insulin prescription and oral hypoglycemic agents were retrieved from the Kaiser Permanente pharmacy databases.
Baseline date was set at entry date into the cohort, which was either (I) date at which patients reached the age of 50 for those with type 1 diabetes during the study period, or (II) date of first type 1 diagnostic code during the study period for those aged 50 years and above. Members were followed until incident dementia diagnosis, lapse in of KPNC membership, death, or end of study (September 30, 2015) . Lapse in KPNC membership was defined as a membership lapse of ≥ 90 days. Deaths were captured using information from Kaiser Permanente electronic medical records and the California Automated Mortality Linkage System, an ascertainment method standard for epidemiological studies of KPNC members. [11] [12] [13] After exclusion of 42 patients with prevalent dementia, the full cohort consisted of 3742 patients with type 1 diabetes.
Dementia
Diagnoses of dementia were identified from electronic medical records, using the following ICD-9 diagnostic codes made in primary care, neurology, or memory clinic visits: Alzheimer disease (331.0), vascular dementia (290.4x), and nonspecific dementia (290.0, 290.1x, 290.2x, 290.3, 294.1x, 294.2x, and 294.8). Using ICD-9 codes in determining dementia diagnosis has been used successfully in several other publications. [14] [15] [16] [17] A similar combination of ICD-9 codes had a sensitivity of 77% and a specificity of 95% compared with a consensus diagnosis of dementia based on a structured interview with informants, neuropsychiatric battery, physical examination, and review of medical records. 18 Diagnoses for frontotemporal dementia (ICD-9 331.1x) and dementia with Lewy Bodies (ICD-9 331.82) were eligible but no cases were identified.
Diabetic Retinal Disease
To best capture all diagnoses of diabetic retinal disease at baseline and through follow-up period, both ICD-9 diagnostic and Current Procedural Terminology, 4th edition (CPT-4) procedural codes were used. An individual was considered to have DR if they had at least one diagnosis code for proliferative DR (PDR) (ICD-9: 362.02; CPT-4: 67228), macular edema (ICD-9: 362.07, 362.53, 362.83; CPT-4: 67208, 67210) or nonspecific DR (ICD-9: 250.5x, 362.0x). A prior study demonstrated a 88% sensitivity and 75% specificity of a similar set of ICD-9 codes compared with medical record review. 19 To evaluate if there were possible differences by severity, severe DR (SDR) encompassed codes for PDR and macular edema. PDR was also examined separately.
Covariates
These analyses include demographics and comorbidities from the year of cohort entry as potential confounders. Age, sex, and race were retrieved from KPNC health plan membership databases. Glycosylated hemoglobin (HbA1c) measurements was obtained from the Kaiser Permanente laboratory, using the last measurement before baseline in tertiles. The following comorbidities that might influence the association between DR and dementia were collected from the KPNC electronic medical records, using the ICD-9 and CPT-4 codes as described in Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/WAD/ A190: severe hypoglycemic and hyperglycemic episodes for which hospital admittance or emergency room visit was necessary, diagnoses of neuropathy, diabetic nephropathy, end-stage renal disease, cardiovascular disease (heart failure, acute myocardial infarction, and peripheral arterial disease), and stroke.
Statistical Analysis
First, the distribution of dementia, sociodemographic variables, and several risk factors or complications associated with diabetes and/or dementia were analyzed by DR status at baseline using χ 2 analyses or the Student t test. Cox proportional hazards models with age as a timescale were implemented to estimate the effect of DR on dementia risk, with DR as a time-dependent covariate. Three models were examined: no adjustment for covariates except for age as the timescale (model 1), adjustment for sex and race (model 2), and additional adjustment for HbA1c, acute hypoglycemia and hyperglycemia, neuropathy, diabetic nephropathy, endstage renal disease, cardiovascular disease, and stroke (model 3). As dementia risk is so closely related to age, stratified analyses were also performed on subsets of the cohort aged 60 years and above or 70 years and above. Among the cohort aged 50 years and above, a sensitivity analysis examined the association between DR and dementia risk further adjusting for hypertension. In additional sensitivity analyses, we excluded time-updated DR cases occurring during the 12 months before dementia diagnosis to minimize the possibility of reverse causation. Sensitivity analyses also evaluated increasingly severe definitions of baseline DR (SDR and PDR). Associations were considered significant at the level of 0.05. SAS statistical software version 9.3 (SAS Institute Inc., Cary, NC) was used for all analyses.
RESULTS
Patients were born between 1900 and 1965 and the mean age at entry was 56.1 (SD = 8.5). In total, 182 patients (4.9%) were diagnosed with dementia during follow-up (mean = 6.2 y) ( Table 1) . Overall 53% of the cohort was male and 21% of the cohort was nonwhite. At baseline, 2294 patients (61.3%) had DR, 1423 (38.0%) had PDR, and 1473 (39.4%) had SDR. Individuals with DR at baseline were younger (55.3 vs. 57.3 y) at entry and had longer follow-up time (6.7 vs. 5.3 y) than their counterparts without DR. Individuals with DR had higher HbA1c% (8.5% vs. 8.0%), and were more likely to have had a stroke, cardiovascular diseases, and hypoglycemic episodes. The subgroup aged 60 years and above consisted of 2021 patients, of which 1343 (66.5%) had DR, 870 (43.1%) had PDR, 907 (44.9%) had SDR, and 157 patients (7.8%) were diagnosed with dementia during follow-up. The subgroup aged 70 years and above consisted of 783 patients, of which 548 (70.0%) had DR, 380 (48.5%) had PDR, 394 (50.3%) had SDR, and 99 patients (12.6%) were diagnosed with dementia during follow-up.
In models only adjusting for age, patients with diabetic retinal disease had a nonsignificant increase of 22% in dementia risk compared with those without DR (adjusted hazard ratio (aHR) = 1.22; 95% confidence interval (CI), 0.89-1.67) ( Table 2 ). Further adjustment for individual covariates slightly changed the hazard ratio, but it remained insignificant. In fully adjusted models, the association was insignificant (aHR = 1.12, 95% CI, 0.82-1.54). All demographics, comorbidities, and risk factors except neuropathy were associated with elevated risk of dementia in models adjusting for age and DR (Supplemental Table  S2 , Supplemental Digital Content 1, http://links.lww.com/ WAD/A190). Results were similar, with slightly lower hazard ratios, when excluding cases of DR occurring within a 12-month period before dementia diagnosis (Table 3) . DR was not associated with dementia risk and had a nonsignificant trend towards a protective effect as the age of the cohort increased (Tables 2, 3 ). In sensitivity analyses examining increasing levels of DR severity as baseline variables, comparable hazard ratios were found. In models adjusted for demographics, neither SDR (aHR = 1.08; 95% CI, 0.81-1.44) nor PDR (aHR = 1.11; 95% CI, 0.83-1.49) were associated with dementia risk, and hazard ratios were comparable with that of DR as a baseline variable adjusted for demographics (aHR = 1.24; 95% CI, 0.90-1.70). In the main and sensitivity analyses among subgroups aged above 60 and 70 years, similar results were seen, albeit with consistently lower hazard ratios in the higher age groups. In sensitivity analyses examining the association between DR and dementia among patients 50 years and above, further adjusted for hypertension did not alter the effect estimate.
DISCUSSION
In this large cohort of elderly patients with type 1 diabetes mellitus, there was no evidence DR that was associated with an increased risk of dementia. These results were consistently found in unadjusted, minimally adjusted, and fully adjusted Cox proportional hazard models. Similar results were found in sensitivity analyses with a 12-month buffer of DR diagnoses before dementia diagnosis, when investigating more SDR as an exposure variable, and in analyses restricted to older age groups.
Characteristics of the cohort in the present study were comparable with the few previously published large community based cohorts of elderly with type 1 diabetes. Sex distribution, average HbA1c values, and dementia incidence were similar to previous studies among older patients with type 1 diabetes. 2, [20] [21] [22] Self-reported DR in a study among patients with type 1 diabetes (n = 309; mean age, 65.7 ± 8.5 y) was 71.5% 20 compared with 61.3% (full cohort), and 66.5% (subgroup aged 60 y and above) in the current study. PDR based on fundus photography (n = 351; mean age, 67.5 ± 7.5 y) was 48.5% in a previous study, versus 43% (subgroup aged 60 y and above) in the current study. 21 Furthermore, the relations between other known risk factors of dementia (eg, stroke 23 ) and dementia were as expected and increased risk, supporting the validity of our observations.
The results from the current study can provide important insight into what potentially mediates an increased risk of dementia in type 1 diabetes. The main theoretical basis for an association between DR and dementia relies on the many similarities between retinal and cerebral small vessels, the latter of which has been greatly supported for its roll in dementia. 24 Indeed, retinal and cerebral microvasculature have similar embryological origin, anatomic features, and physiological properties, including barrier functions (blood-brain, and blood-retinal barrier), autoregulation and a relatively low-flow and high-oxygen extraction system. These similarities in anatomy and function are not surprising, as both provide for glia cells and neurons, and thus have similar functions. 25 Moreover, several studies have found an association between retinal vascular changes and cerebral small vessel disease. [26] [27] [28] [29] Although all analyses were statistically insignificant, it is interesting to see that the hazard ratio for dementia associated with DR and other dementia risk factors is smaller among the older age groups for all analyses. This is in agreement with several other studies among type 1 diabetes, 2 and all cause diabetes, 30 that found that the impact of diabetes on dementia becomes progressively attenuated in the older age groups. This is consistent with diabetes and diabetes-related risk factors such as DR accelerating the development of dementia in those prone to the disease, lowering the age of dementia onset, and decreasing the incidence of DR-related dementia in older age groups.
Prior studies on the relationship between type 1 diabetes and dementia are in line with a theory of DR-related dementia being mainly in younger age groups or during time of onset of DR. Studies among younger cohorts with type 1 diabetes found associations between DR and subtle cognitive dysfunction, 31, 32 diabetes-associated cognitive decrements, 33 lower brain volume, and more vascular lesions on magnetic resonance imaging. 34 However, these studies were conducted in younger patients, thus extrapolation to older groups with regard to dementia risk, retinopathy risk, and type 1 diabetes disease burden is not straightforward. In the older general population, retinopathy was found to be associated with clinically diagnosed dementia in cross-sectional comparisons [35] [36] [37] but not longitudinally. 38 Furthermore, a large cross-sectional study (N = 2211) found a significant association only for those without diabetes after stratification by diabetes status (289 patients with diabetes, diabetes types not specified). 39 Lastly, the contrast between the results of the current study and a comparable study among patients with type 2 diabetes aged 60 years and above (N = 29,961) 7 which did find DR to increase dementia risk indicates differences between these types 1 and 2 diabetes cohorts with regard to DR and dementia. The study used similar data collection methods from the KPNC database and found DR to be significantly associated with dementia, with a fully adjusted HR of 1.29 (95% CI, 1.14-1.45). Notably, the incidence of SDR diagnoses in the study on type 2 diabetes was much lower than the age-matched subgroup in the current study (7% vs. 55.1% in those aged 60 y and above), and the Estimates obtained from Cox proportional hazards models with age as timescale. *Baseline comorbidities include neuropathy, diabetic nephropathy, end-stage renal disease, cardiovascular disease, stroke, and hyperglycemic or hypoglycemic episodes.
CI indicates confidence interval; HR, hazard ratio.
incidence of dementia was higher than that of the current study (17% vs. 7.8% aged 60 y and above). However, caution is needed when interpreting this as an indication of differences in etiological underpinnings of dementia for type 1 versus type 2 diabetes, as other distinctions between the cohorts could explain the contrast. First, attenuation due to selective survivorship could play a larger role in the current cohort. However, as survivorship bias would be expected to affect other risk factors as well, the insignificance of the association between DR and dementia still contrasts the significant association found for other risk factors (Supplemental Table 2 , Supplemental Digital Content 1, http:// links.lww.com/WAD/A190). Another explanation could lie in possible differences in DR duration between both cohorts. As stated before, DR might be associated with dementia mainly during onset of the disease, after which the association attenuates. DR might therefore not be associated with dementia in a population that acquired it many years before analysis when excluding prevalent dementia cases. This is supported by sensitivity analyses by Exalto et al, 7 which demonstrate an attenuation of the association between DR and dementia with longer time between occurrence of DR and dementia incidence. In the current study, sensitivity analyses censoring DR diagnosis 12 months before dementia diagnosis also showed attenuation of the point estimates. Finally, these characteristics from cohorts with the same age, from the same source using similar methods could indicate true differences in etiological underpinnings of dementia for type 1 versus type 2 diabetes, such that the relative impact of DR pathology on dementia is lower in type 1 diabetes compared with type 2 diabetes. The present study has several strengths. It is the first study investigating the association between DR and dementia in a large population of older patients with type 1 diabetes. Analyses included information on a wide variety of diabetes specific comorbidities and the longitudinal design of this study allowed for incident dementia to be observed. Furthermore, due to detailed information on date of diagnosis, robust statistical methods using DR as a time-dependent variable could be used to test the association between DR and dementia.
There were several limitations to this study. Most importantly, the lack of information regarding age of diabetes and DR onset. Age of onset of diabetes might significantly affect both DR risk 40 and dementia. Type 1 diabetes generally onsets during childhood, 41 and several studies have shown that early childhood is a crucial period in which diabetes affects cognition. 42 Furthermore, information on age of onset of DR could illuminate possible close temporal relations between DR and dementia onset. Second, this study was performed in a uniquely large group of patients with type 1 diabetes who survived to older ages, despite being born in a time when mortality for those diagnosed with diabetes was over 50%. 1 This invokes the risk of survivorship bias, as the current study population includes a healthy survivor group that outlived many peers, and may underestimate the relationship between DR and dementia. However, our sample may also include individuals who were diagnosed with type 1 diabetes later in life, reducing the risk of selective survivorship. Lastly, the use of medical record diagnoses for dementia could be a potential weakness. Although this method has been shown to have a relatively high sensitivity (77%) and specificity (95%) for the diagnosis of dementia compared with a consensus diagnosis, 18 it did not allow for stratification by type of dementia as all but a few ICD-9 codes for dementia were unspecified.
In conclusion, in this first study of DR and dementia in older patients with type 1 diabetes, DR was not found to be associated with risk of dementia. This study conflicts the hypothesis that pathophysiological processes underlying DR are also involved in the development of dementia, in older aged patients with type 1 diabetes. Furthermore, the current findings are consistent with different pathophysiological mechanisms involved in the development of dementia in type 1 versus type 2 diabetes. This indicates the need for separation of both types of diabetes when investigating pathophysiology of dementia. As those with type 1 diabetes are living longer than ever before, further investigation of these mechanisms can aid in a broader understanding of dementia and more specific preventative measures for this patient group.
